| Literature DB >> 29703927 |
Stéphane Beauclercq1, Lydie Nadal-Desbarats2, Christelle Hennequet-Antier1, Irène Gabriel1, Sophie Tesseraud1, Fanny Calenge3, Elisabeth Le Bihan-Duval1, Sandrine Mignon-Grasteau4.
Abstract
The increasing cost of conventional feedstuffs has bolstered interest in genetic selection for digestive efficiency (DE), a component of feed efficiency, assessed by apparent metabolisable energy corrected to zero nitrogen retention (AMEn). However, its measurement is time-consuming and constraining, and its relationship with metabolic efficiency poorly understood. To simplify selection for this trait, we searched for indirect metabolic biomarkers through an analysis of the serum metabolome using nuclear magnetic resonance (1H NMR). A partial least squares (PLS) model including six amino acids and two derivatives from butyrate predicted 59% of AMEn variability. Moreover, to increase our knowledge of the molecular mechanisms controlling DE, we investigated 1H NMR metabolomes of ileal, caecal, and serum contents by fitting canonical sparse PLS. This analysis revealed strong associations between metabolites and DE. Models based on the ileal, caecal, and serum metabolome respectively explained 77%, 78%, and 74% of the variability of AMEn and its constitutive components (utilisation of starch, lipids, and nitrogen). In our conditions, the metabolites presenting the strongest associations with AMEn were proline in the serum, fumarate in the ileum and glucose in caeca. This study shows that serum metabolomics offers new opportunities to predict chicken DE.Entities:
Mesh:
Year: 2018 PMID: 29703927 PMCID: PMC5923279 DOI: 10.1038/s41598-018-24978-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Distribution of phenotypic values of digestive efficiency traits for the 56 chickens selected for metabolomics (violin plots). AMEn: fecal apparent metabolisable energy corrected to zero nitrogen retention at 24–25 d, CDUDM_w2: fecal coefficient of digestive use of dry matter at 2 weeks, CDUDM_w4: fecal coefficient of digestive use of dry matter at 4 weeks, CDUL: fecal coefficient of digestive use of lipids at 4 weeks, CDUS: fecal coefficient of digestive use of starch at 4 weeks, CDUN: fecal coefficient of digestive use of nitrogen at 4 weeks. The means are indicated by a green triangle.
Figure 2Representative spectra of (A) caecal and (B) ileal contents. 1. TSP; 2. Butyrate/valerate; 3. Ile/Leu/Val; 4. Propionate; 5. Lactate; 6. Ala; 7. Lys/putrescine/5-aminovalerate; 8. Acetate; 9. Pro; 10. Butyrate/propionate/valerate; 11. Glu; 12. Succinate; 13. 2-oxoisocaproate/Met/Asp; 14. Asp/3-(3-hydroxyphenyl)propionate; 15. Lys/5-aminovalerate; 16. Malonate; 17. Choline; 18. Glucose; 19. Methanol (extraction); 20. Glucose/Taurine; 21. Lys/Glu/Gln/Leu/Ala; 22. Xylose/galactose; 23. Uracil; 24. Uridine; 25. 3-(3-Hydroxyphenyl)propionate/4-hydroxyphenylacetate/4-hydroxybenzoate; 26. 4-Hydroxyphenylacetate; 27. Phenylacetate/Phe; 28. Nicotinate; 29. Deoxycytidine; 30. Nicotinate/deoxyadenosine; 31. Deoxyadenosine; 32 Leu/Lys/Arg; 33. Glu; 34. Met/Glu/Gln; 35. Glu/Gln/succinate; 36. Creatine; 37. Glucose/galactose; 38. Phe; 39. Galactose; 40. Tyr; 41. His; 42. Trp; 43. Formate.
Figure 3PLS regression from serum at 25 d (12 variables, 2 components, R2X = 0.639, R2Y = 0.591, Q2 = 0.48, CV-ANOVA = 1.12 × 10−6). (A) Score plot (t[z]: component z on the X space), (B) contribution of the variables through the loadings and their confidence interval (w*c[1]: X and Y loadings on component 1), and (C) predicted versus observed AMEn value (YPred: AMEn predicted, YVar: AMEn observed). 3-HObutyrate: 3-hydroxybutyrate, 3-HO-isobutyrate: 3-hydroxyisobutyrate, 5.1876: unknown metabolite with a chemical shift of 5.1876 ppm.
Figure 4Global metabolic network between metabolites retained by sPLS and digestive efficiency traits (coefficients of digestive use of nitrogen, starch, lipids, and metabolisable energy at 4 weeks). This network combines metabolites from the ileal content (“I” or yellow node), caecal content (“C” or cyan node), and serum (“S” pink node). The edges are coloured according to the association score (cut-off at ±0.5).
Metabolite Set Enrichment Analysis performed on the list of 11 serum and 25 digestive content metabolites associated to DE derived from the global metabolic network.
| Pathway | Match (a/b) | FDR p-value | Metabolites |
|---|---|---|---|
|
| |||
| Protein biosynthesis | 8/19 | 1.89 × 10−10 | Phenylalanine, proline, isoleucine, leucine, methionine, valine, tryptophan, glutamate |
| Valine, leucine, isoleucine degradation | 4/36 | 0.03 | 3-Hydroxyisobutyrate, isoleucine, leucine, valine |
|
| |||
| Protein biosynthesis | 12/19 | 5.24 × 10−14 | Glutamate, tyrosine, phenylalanine, alanine, proline, asparagine, histidine, lysine, aspartate, glutamine, leucine, methionine |
| Ammonia recycling | 5/18 | 0.0036 | Glutamate, asparagine, histidine, aspartate, glutamine |
| Urea cycle | 5/20 | 0.0042 | Fumarate, glutamate, alanine; aspartate, glutamine |
| Aspartate metabolism | 4/12 | 0.0047 | Fumarate, asparagine, aspartate, malonate |
In the match column, “a” corresponds to the number of metabolites observed by NMR in the pathway and “b” to the total number of metabolites implicated in the same pathway. Only the pathways with a p-value corrected by FDR lower than 0.05 were considered.
Figure 5Experimental scheme.